chr8-22727216-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_144962.3(PEBP4):āc.362C>Gā(p.Ala121Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000248 in 1,613,660 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_144962.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PEBP4 | NM_144962.3 | c.362C>G | p.Ala121Gly | missense_variant | 5/7 | ENST00000256404.8 | NP_659399.2 | |
PEBP4 | NM_001363233.2 | c.362C>G | p.Ala121Gly | missense_variant | 5/7 | NP_001350162.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PEBP4 | ENST00000256404.8 | c.362C>G | p.Ala121Gly | missense_variant | 5/7 | 1 | NM_144962.3 | ENSP00000256404.6 | ||
ENSG00000253125 | ENST00000523627.1 | n.165-17378G>C | intron_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.000131 AC: 20AN: 152116Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000443 AC: 11AN: 248246Hom.: 0 AF XY: 0.0000297 AC XY: 4AN XY: 134590
GnomAD4 exome AF: 0.0000137 AC: 20AN: 1461544Hom.: 0 Cov.: 33 AF XY: 0.00000963 AC XY: 7AN XY: 727020
GnomAD4 genome AF: 0.000131 AC: 20AN: 152116Hom.: 0 Cov.: 31 AF XY: 0.000121 AC XY: 9AN XY: 74318
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2024 | The c.362C>G (p.A121G) alteration is located in exon 5 (coding exon 4) of the PEBP4 gene. This alteration results from a C to G substitution at nucleotide position 362, causing the alanine (A) at amino acid position 121 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at